Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Rectal Neoplasms and DPYD[original query] |
---|
X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients. International journal of radiation oncology, biology, physics 2012 Jan 82 (1): 138-44. Lamas Maria J, Duran Goretti, Gomez Antonio, Balboa Emilia, Anido Urbano, Bernardez Beatriz, Rana-Diez Pablo, Lopez Rafael, Carracedo Angel, Barros Francis |
Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer. British journal of cancer 2011 Nov 105 (11): 1654-62. Thomas F, Motsinger-Reif A A, Hoskins J M, Dvorak A, Roy S, Alyasiri A, Myerson R J, Fleshman J W, Tan B R, McLeod H |
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: